Renol Polychem

Is Renol Polychem overvalued or undervalued?

As of December 4, 2025, Renol Polychem is considered very attractive and undervalued, with a PE ratio of 23.83, an EV to EBIT of 16.60, and a ROCE of 19.71%, outperforming peers like Sudarshan Chem and Kiri Industries, and showing a 1-month return of 14.81% compared to the Sensex's 1.70%.

As of 4 December 2025, the valuation grade for Renol Polychem has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of 23.83, an EV to EBIT of 16.60, and a ROCE of 19.71%. <BR><BR>In comparison to peers, Renol Polychem's PE ratio is significantly lower than Sudarshan Chem's 130.12 and Kiri Industries' 30.05, both of which are in less favorable valuation positions. Additionally, Renol's EV to EBITDA ratio of 16.28 is more attractive than that of Indokem, which stands at 239.79. The recent stock performance shows a 1-month return of 14.81%, outperforming the Sensex's 1.70% return, reinforcing the notion that Renol Polychem is positioned well in the market.

Why is Renol Polychem Ltd falling/rising?

As of 04-Mar, the stock price of Renol Polychem Ltd is stable at 139.75, with a recent decline of 3.35% over the past week. Despite being above longer-term moving averages, short-term weakness and reduced investor participation suggest a cautious outlook.

As of 04-Mar, the stock price of Renol Polychem Ltd is currently stable at 139.75, showing no change (0.00%). Over the past week, the stock has experienced a decline of 3.35%, which is slightly better than the benchmark Sensex, which fell by 3.93%. In the last month, the stock has decreased by 4.61%, while the Sensex has dropped by 5.03%. Year-to-date, Renol Polychem Ltd has a minor decline of 0.89%, compared to the Sensex's larger drop of 6.31%.<BR><BR>Despite the current price stability, the stock has shown mixed performance in terms of moving averages. It is above the 100-day and 200-day moving averages, indicating some longer-term strength, but it is below the 5-day, 20-day, and 50-day moving averages, suggesting short-term weakness. Additionally, there has been a significant drop in investor participation, with delivery volume on March 2 falling by 69.61% compared to the 5-day average, indicating reduced trading interest.<BR><BR>Overall, while the stock is not currently falling or rising, the recent decline in investor participation and mixed moving average performance may contribute to a cautious outlook for Renol Polychem Ltd.

Which are the latest news on Renol Polychem?